Overall rates of tissue protein degradation in vivo during chemical he
patocarcinogenesis were estimated by a double-isotope method as well a
s from the accumulation of peptide intermediates in protein degradatio
n induced by bestatin. Several parameters estimating rates of cell pro
liferation and cell loss have been measured in parallel. The two proce
dures adopted consistently indicated that protein turnover was signifi
cantly slowed down through the whole observation period (12 months aft
er the initiating administration of DENA) in both 'preneoplastic' nodu
les and hepatomas as compared with control livers or perinodular tissu
e. Such a difference may confer a selective growth advantage to 'prene
oplastic' and tumoral cells. Since protein degradation rates did not a
ppreciably differ between nodules and hepatomas, either such advantage
originated from some early step in the carcinogenetic process or it m
erely reflected the proliferative events in the two cell populations.
Yet neither liver nodules nor hepatomas were characterized by very hig
h rates of cell proliferation, however much increased with respect to
control liver.